<--- Back to Details
First PageDocument Content
Pharmacology / Cinacalcet / Drugs / Quality-adjusted life year / Clinical trial / Secondary hyperparathyroidism / Amgen / Cost-effectiveness analysis / Pharmaceutical Benefits Scheme / Health / Medicine / Health economics
Date: 2015-03-23 21:11:42
Pharmacology
Cinacalcet
Drugs
Quality-adjusted life year
Clinical trial
Secondary hyperparathyroidism
Amgen
Cost-effectiveness analysis
Pharmaceutical Benefits Scheme
Health
Medicine
Health economics

Add to Reading List

Source URL: www.pbs.gov.au

Download Document from Source Website

File Size: 33,06 KB

Share Document on Facebook

Similar Documents

PDF Document

DocID: 1xvUb - View Document

PDF Document

DocID: 1xc8R - View Document

Institute of Pharmacology www.pki.unibe.ch Introduction Prof. Dr. Dr. Stephan von Gunten MD PhD MME

DocID: 1vqsj - View Document

Jansone et al.: Intrinsic Activity, 2017; 5 (Suppl.2):A1.6 doi:IA.5.S2-A1.6 published online: 16 October 2017 2nd International Conference in Pharmacology: From Cellular Processes to Drug Targets Rīga, Latvia

DocID: 1vlJU - View Document

Human cells Notable for research in: -Medecine: Diseases and cancers -Cell Biology -Pharmacology

DocID: 1vk1K - View Document